Current Understanding of Epithelial-Derived Alarmins in Chronic Rhinosinusitis with Nasal Polyps
- PMID: 40533675
- DOI: 10.1007/s12016-025-09073-y
Current Understanding of Epithelial-Derived Alarmins in Chronic Rhinosinusitis with Nasal Polyps
Abstract
Chronic rhinosinusitis with nasal polyps (CRSwNP) is a multifactorial inflammatory condition characterized by persistent sinus inflammation and tissue remodeling. Epithelial-derived alarmins, including thymic stromal lymphopoietin (TSLP), interleukin-33 (IL-33), and interleukin-25 (IL-25), are critical mediators that initiate and amplify immune responses in CRSwNP. These alarmins are secreted by stressed or damaged nasal epithelial cells in response to environmental insults, such as allergens, microbial infections, pollutants, and proteases. Once released, they orchestrate immune cell activation and amplify inflammatory pathways. Targeting epithelial-derived alarmins has emerged as a promising therapeutic strategy for CRSwNP, with several biologics, including TSLP and IL-33 inhibitors, showing encouraging clinical outcomes. This review focuses on the role of epithelial-derived alarmins in CRSwNP, examining their expression patterns, regulatory mechanisms, and contributions to inflammation, evaluating the current progress in alarmin-targeted therapies, and exploring future research directions to optimize their clinical application.
Keywords: Chronic rhinosinusitis with nasal polyps; Epithelial alarmins; IL-25; IL-33; TSLP; Type 2 inflammation.
© 2025. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Conflict of interest statement
Declarations. Ethical Approval: This article is a review of previously published studies. No new studies involving human participants or animals were conducted by the authors. Competing Interests: The authors declare no competing interests.
Similar articles
-
Thymic stromal lymphopoietin activity is increased in nasal polyps of patients with chronic rhinosinusitis.J Allergy Clin Immunol. 2013 Sep;132(3):593-600.e12. doi: 10.1016/j.jaci.2013.04.005. Epub 2013 May 17. J Allergy Clin Immunol. 2013. PMID: 23688414 Free PMC article.
-
Tezepelumab inhibits highly functional truncated thymic stromal lymphopoietin in chronic rhinosinusitis.J Allergy Clin Immunol. 2025 Aug;156(2):463-467.e2. doi: 10.1016/j.jaci.2025.02.031. Epub 2025 Mar 6. J Allergy Clin Immunol. 2025. PMID: 40057283
-
GLUT1 Promotes Squamous Metaplasia in Eosinophilic Chronic Rhinosinusitis with Nasal Polyps.Am J Rhinol Allergy. 2025 Sep;39(5):353-363. doi: 10.1177/19458924251342999. Epub 2025 May 19. Am J Rhinol Allergy. 2025. PMID: 40388707
-
Reappraisal of Biologic Efficacy from Phase 3 Trials in Refractory Chronic Rhinosinusitis and Nasal Polyps.J Allergy Clin Immunol Pract. 2025 Aug;13(8):1943-1951. doi: 10.1016/j.jaip.2025.04.043. Epub 2025 May 6. J Allergy Clin Immunol Pract. 2025. PMID: 40340024 Review.
-
Chinese Position Paper on Biologic Therapy for Chronic Rhinosinusitis With Nasal Polyps.Allergy. 2025 May;80(5):1208-1225. doi: 10.1111/all.16519. Epub 2025 Mar 5. Allergy. 2025. PMID: 40042059 Free PMC article. Review.
Cited by
-
Decreased IL-33 in the brain following repetitive mild traumatic brain injury contributes to cognitive impairment by inhibiting microglial phagocytosis.Mil Med Res. 2025 Aug 5;12(1):46. doi: 10.1186/s40779-025-00631-1. Mil Med Res. 2025. PMID: 40764944 Free PMC article.
References
-
- Stevens WW, Schleimer RP, Kern RC (2016) Chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol Pract 4(4):565–572. https://doi.org/10.1016/j.jaip.2016.04.012 - DOI - PubMed - PMC
-
- Laidlaw TM, Mullol J, Woessner KM, Amin N, Mannent LP (2021) Chronic rhinosinusitis with nasal polyps and asthma. J Allergy Clin Immunol Pract 9(3):1133–1141. https://doi.org/10.1016/j.jaip.2020.09.063 - DOI - PubMed
-
- Fokkens WJ, Lund VJ, Hopkins C, Hellings PW, Kern R, Reitsma S et al (2020) European Position Paper on Rhinosinusitis and Nasal Polyps 2020. Rhinology 58(Suppl S29):1–464. https://doi.org/10.4193/Rhin20.600
-
- Hong H, Liao S, Chen F, Yang Q, Wang DY (2020) Role of IL-25, IL-33, and TSLP in triggering united airway diseases toward type 2 inflammation. Allergy 75(11):2794–2804. https://doi.org/10.1111/all.14526 - DOI - PubMed
-
- Gevaert P, Han JK, Smith SG, Sousa AR, Howarth PH, Yancey SW et al (2022) The roles of eosinophils and interleukin-5 in the pathophysiology of chronic rhinosinusitis with nasal polyps. Int Forum Allergy Rhinol 12(11):1413–1423. https://doi.org/10.1002/alr.22994 - DOI - PubMed - PMC
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical